Soleno Therapeutics (SLNO) Free Cash Flow: 2013-2024
Historic Free Cash Flow for Soleno Therapeutics (SLNO) over the last 12 years, with Dec 2024 value amounting to -$69.3 million.
- Soleno Therapeutics' Free Cash Flow fell 35.93% to -$5.1 million in Q4 2019 from the same period last year, while for Dec 2019 it was -$17.4 million, marking a year-over-year decrease of 48.81%. This contributed to the annual value of -$69.3 million for FY2024, which is 177.94% down from last year.
- Per Soleno Therapeutics' latest filing, its Free Cash Flow stood at -$69.3 million for FY2024, which was down 177.94% from -$24.9 million recorded in FY2023.
- In the past 5 years, Soleno Therapeutics' Free Cash Flow ranged from a high of -$20.8 million in FY2022 and a low of -$69.3 million during FY2024.
- For the 3-year period, Soleno Therapeutics' Free Cash Flow averaged around -$38.4 million, with its median value being -$24.9 million (2023).
- In the last 5 years, Soleno Therapeutics' Free Cash Flow climbed by 25.18% in 2022 and then plummeted by 177.94% in 2024.
- Yearly analysis of 5 years shows Soleno Therapeutics' Free Cash Flow stood at -$25.2 million in 2020, then declined by 10.15% to -$27.8 million in 2021, then rose by 25.18% to -$20.8 million in 2022, then dropped by 19.94% to -$24.9 million in 2023, then plummeted by 177.94% to -$69.3 million in 2024.